United States Healthcare Providers & Services

CVS Health Corp (CVS)

Track

Over the past 90 days, CVS Health Corp has seen significant insider selling activity, totaling approximately $333.2 million in sales with no recorded purchases. Notable transactions include substantial divestments by Larry Robbins. These sales occurred following the company's May 2026 earnings report, which showed a 16.3% earnings beat, amid a 29.8% stock price increase over the period.
Ticker: CVS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CVS Health Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 21 May 2026
Value US$4,449,627.11 | Price 111.48 | Shares 1,066 (-0.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-21 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
1,066 -0.9%
111.48
US$4,449,627 		1,066 -0.9% 111.48 US$4,449,627
2026-05-21 2026-05-21 PrS Proposed sale
1.3
FARAH ROGER N

Director

Non-Executive Director
5,948
364.47
US$3,840,158 		5,948 364.47 US$3,840,158
2026-05-22 2026-05-20 PrS Proposed sale
3.2
AGUIRRE FERNANDO

Director

Non-Executive Director
17,807
226.34
US$2,563,690 		17,807 226.34 US$2,563,690
2026-05-22 2026-05-20 PrS Proposed sale
3.2
AGUIRRE FERNANDO

Director

Non-Executive Director
2,263
94.69
US$214,283 		2,263 94.69 US$214,283
2026-05-21 2026-05-20 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
800 -0.0%
96.28
US$77,026 		800 -0.0% 96.28 US$77,026
2026-05-21 2026-05-20 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
66,881 -1.3%
95.67
US$6,398,204 		66,881 -1.3% 95.67 US$6,398,204
2026-05-21 2026-05-20 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
152,691 -2.8%
94.81
US$14,476,038 		152,691 -2.8% 94.81 US$14,476,038
2026-05-21 2026-05-20 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
797,628 -12.8%
93.48
US$74,559,554 		797,628 -12.8% 93.48 US$74,559,554
2026-05-21 2026-05-19 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
151 -0.0%
95.18
US$14,372 		151 -0.0% 95.18 US$14,372
2026-05-21 2026-05-19 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
1,983,387 -24.2%
94.45
US$187,326,935 		1,983,387 -24.2% 94.45 US$187,326,935
2026-05-11 2026-05-08 S Sale
Mandadi Tilak

EVP, Chief Exp & Tech Officer

Officer
69,551 -87.3%
89.58
US$6,230,379 		69,551 -87.3% 89.58 US$6,230,379
2026-05-08 2026-05-08 PrS Proposed sale
TILAK MANDADI

Officer

Officer
69,551
89.58
US$6,230,719 		69,551 89.58 US$6,230,719
2025-08-29 2025-08-20 S Sale
0.8
Finucane Anne A.
Non-Executive Director
7,500 -25.3%
71.02
US$532,650 		7,500 -25.3% 71.02 US$532,650
2025-08-19 2025-08-20 PrS Proposed sale
0.8
Finucane Anne A.

Director

Non-Executive Director
7,500
70.97
US$532,275 		7,500 70.97 US$532,275
2025-06-09 2025-06-05 B Purchase
3.1
SANSONE GUY P
Non-Executive Director
1,570 +15.0%
63.70
US$100,009 		1,570 +15.0% 63.70 US$100,009
2025-05-06 2025-05-06 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
150,000 -1.8%
66.67
US$10,000,710 		150,000 -1.8% 66.67 US$10,000,710
2025-05-06 2025-05-05 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
96,999 -1.1%
67.99
US$6,595,272 		96,999 -1.1% 67.99 US$6,595,272
2025-05-06 2025-05-05 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
1,226,933 -12.7%
67.37
US$82,654,673 		1,226,933 -12.7% 67.37 US$82,654,673
2025-05-06 2025-05-02 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
373,776 -3.7%
69.66
US$26,035,592 		373,776 -3.7% 69.66 US$26,035,592
2025-05-06 2025-05-02 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
222,556 -2.2%
68.38
US$15,218,980 		222,556 -2.2% 68.38 US$15,218,980
2025-05-06 2025-05-02 S Sale
3.4
ROBBINS LARRY
Non-Executive Director
1,679,736 -14.1%
67.39
US$113,190,186 		1,679,736 -14.1% 67.39 US$113,190,186
2025-03-07 2025-03-05 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
7,513 -47.2%
66.35
US$498,488 		7,513 -47.2% 66.35 US$498,488
2025-03-05 2025-03-05 PrS Proposed sale
3.6
Clark James David

Officer

Officer
7,513
66.35
US$498,489 		7,513 66.35 US$498,489
2025-02-19 2025-02-18 B Purchase
2.8
Mahoney Michael F
Non-Executive Director
30,000 +320.6%
66.70
US$2,001,000 		30,000 +320.6% 66.70 US$2,001,000
2026-01-27 2025-01-23 B Purchase
3.1
Nelson Steven H

EVP and President, Aetna

Officer
24 +inf%
53.70
US$1,289 		24 +inf% 53.70 US$1,289
2025-10-14 2024-10-23 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
35 +70.0%
56.85
US$1,990 		35 +70.0% 56.85 US$1,990
2025-10-14 2024-10-02 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
10 +25.0%
62.24
US$622 		10 +25.0% 62.24 US$622
2025-10-14 2024-09-09 B Purchase
3.6
CAPOZZI HEIDI B

EVP and Chief People Officer

Officer
35 +700.0%
56.47
US$1,976 		35 +700.0% 56.47 US$1,976
2024-05-02 2024-05-02 B Purchase
3.2
LUDWIG EDWARD J
Non-Executive Director
1,000 +4.8%
53.88
US$53,879 		1,000 +4.8% 53.88 US$53,879
2024-05-02 2024-05-02 B Purchase
2.8
Mahoney Michael F
Non-Executive Director
9,181 +5246.3%
54.49
US$500,294 		9,181 +5246.3% 54.49 US$500,294
2024-02-16 2024-02-16 PrS Proposed sale
3.1
PREM S SHAH

Officer

Officer
29,473
76.95
US$2,267,924 		29,473 76.95 US$2,267,924
2024-02-16 2024-02-16 S Sale
3.1
Shah Prem S

EVP and Pres-Pharm, Consumer W

Officer
29,473 -42.6%
76.95
US$2,267,947 		29,473 -42.6% 76.95 US$2,267,947
2023-11-06 2023-11-03 B Purchase
3.2
LUDWIG EDWARD J
Non-Executive Director
2,000 +10.7%
70.47
US$140,930 		2,000 +10.7% 70.47 US$140,930
2023-08-04 2023-08-03 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
23,128 -83.1%
74.94
US$1,733,212 		23,128 -83.1% 74.94 US$1,733,212
2023-08-04 2023-08-03 S Sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
2,631 -8.6%
74.79
US$196,792 		2,631 -8.6% 74.79 US$196,792
2023-08-03 2023-08-03 PrS Proposed sale
3.6
Clark James David

Officer

Officer
25,759
74.92
US$1,929,930 		25,759 74.92 US$1,929,930
2023-05-05 2023-05-03 B Purchase
2.1
Lynch Karen S

President and CEO

Executive Director
14,000 +3.4%
69.75
US$976,567 		14,000 +3.4% 69.75 US$976,567
2022-12-16 2022-12-15 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
36,490 -5.7%
98.24
US$3,584,869 		36,490 -5.7% 98.24 US$3,584,869
2022-12-16 2022-12-15 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
100,976 -14.2%
98.40
US$9,936,311 		100,976 -14.2% 98.40 US$9,936,311
2022-08-05 2022-08-04 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
22,541 -17.1%
104.00
US$2,344,264 		22,541 -17.1% 104.00 US$2,344,264
2022-08-05 2022-08-03 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
50,501 -31.6%
98.00
US$4,949,098 		50,501 -31.6% 98.00 US$4,949,098
2022-08-05 2022-08-03 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
70,398 -39.2%
98.00
US$6,899,004 		70,398 -39.2% 98.00 US$6,899,004
2022-08-05 2022-08-03 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
9,546 -22.9%
100.00
US$954,600 		9,546 -22.9% 100.00 US$954,600
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
3,130 -6.7%
105.00
US$328,650 		3,130 -6.7% 105.00 US$328,650
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
4,103 -8.1%
105.00
US$430,815 		4,103 -8.1% 105.00 US$430,815
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
5,719 -10.9%
105.00
US$600,495 		5,719 -10.9% 105.00 US$600,495
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
3,157 -6.3%
105.00
US$331,485 		3,157 -6.3% 105.00 US$331,485
2022-04-12 2022-04-08 PlS Planned sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
845 -1.8%
105.00
US$88,725 		845 -1.8% 105.00 US$88,725
2022-04-06 2022-04-05 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
5,941 -15.6%
100.00
US$594,100 		5,941 -15.6% 100.00 US$594,100
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
12,032 -24.0%
100.13
US$1,204,764 		12,032 -24.0% 100.13 US$1,204,764
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
27,166 -35.1%
100.13
US$2,720,132 		27,166 -35.1% 100.13 US$2,720,132
2022-04-06 2022-04-04 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
16,161 -24.4%
100.13
US$1,618,201 		16,161 -24.4% 100.13 US$1,618,201
2022-03-18 2022-03-17 S Sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
2,935 -4.7%
106.65
US$313,018 		2,935 -4.7% 106.65 US$313,018
2022-03-18 2022-03-17 S Sale
3.1
Shah Prem S

EVP and Co-President of Retail

Officer
1,689 -2.8%
106.65
US$180,132 		1,689 -2.8% 106.65 US$180,132
2022-03-17 2022-03-15 S Sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
51,361 -5.8%
105.00
US$5,392,905 		51,361 -5.8% 105.00 US$5,392,905
2022-02-11 2022-02-10 B Purchase
3.2
LUDWIG EDWARD J
Non-Executive Director
1,000 +5.8%
105.90
US$105,904 		1,000 +5.8% 105.90 US$105,904
2022-02-04 2022-02-03 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
47,937 -25.7%
110.00
US$5,273,070 		47,937 -25.7% 110.00 US$5,273,070
2022-02-02 2022-02-01 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
21,386 -25.9%
106.50
US$2,277,566 		21,386 -25.9% 106.50 US$2,277,566
2022-02-01 2022-01-28 PlS Planned sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
6,059 -25.7%
109.00
US$660,431 		6,059 -25.7% 109.00 US$660,431
2022-01-28 2022-01-27 PlS Planned sale
Roberts Jonathan C

EVP & Chief Operating Officer

Officer
68,482 -39.0%
107.50
US$7,361,815 		68,482 -39.0% 107.50 US$7,361,815
2021-11-05 2021-11-03 PlS Planned sale
Roberts Jonathan C

EVP & Chief Operating Officer

Officer
108,870 -50.4%
95.00
US$10,342,650 		108,870 -50.4% 95.00 US$10,342,650
2021-11-03 2021-11-01 S Sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
28,159 -16.9%
90.00
US$2,534,310 		28,159 -16.9% 90.00 US$2,534,310
2021-10-28 2021-10-26 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
80,802 -36.9%
88.00
US$7,110,576 		80,802 -36.9% 88.00 US$7,110,576
2021-10-28 2021-10-26 S Sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
1,955 -0.9%
88.00
US$172,040 		1,955 -0.9% 88.00 US$172,040
2021-06-29 2021-06-28 PlS Planned sale
2.3
Lotvin Alan

EVP&President-PharmacyServices

Officer
2,781 -4.4%
83.67
US$232,686 		2,781 -4.4% 83.67 US$232,686
2021-06-17 2021-06-15 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
67,552 -32.1%
86.00
US$5,809,472 		67,552 -32.1% 86.00 US$5,809,472
2021-06-08 2021-06-07 PlS Planned sale
Finke Daniel P

EVP/Pres, Health Care Benefits

Officer
37,594 -61.7%
86.60
US$3,255,640 		37,594 -61.7% 86.60 US$3,255,640
2021-05-12 2021-05-10 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
109,469 -100.0%
86.00
US$9,414,334 		109,469 -100.0% 86.00 US$9,414,334
2021-05-10 2021-05-07 PlS Planned sale
1.6
Brennan Troyen A

EVP and Chief Medical Officer

Officer
9,477 -6.1%
84.00
US$796,068 		9,477 -6.1% 84.00 US$796,068
2021-05-06 2021-05-04 PlS Planned sale
2.3
Boratto Eva C

EVP & CFO

Officer
4,905 -4.1%
80.00
US$392,400 		4,905 -4.1% 80.00 US$392,400
2021-04-23 2021-04-21 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
2,420 -100.0%
77.00
US$186,340 		2,420 -100.0% 77.00 US$186,340
2021-04-23 2021-04-21 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
101,003 -97.7%
77.00
US$7,777,231 		101,003 -97.7% 77.00 US$7,777,231
2021-04-01 2021-03-31 PlS Planned sale
3.6
Clark James David

SVP, Cont & Chief Acct Officer

Officer
5,350 -42.5%
76.00
US$406,600 		5,350 -42.5% 76.00 US$406,600
2021-03-30 2021-03-29 PlS Planned sale
2.8
Moriarty Thomas M

EVP & General Counsel

Officer
62,943 -100.0%
76.15
US$4,793,109 		62,943 -100.0% 76.15 US$4,793,109
2021-03-29 2021-03-26 PlS Planned sale
MERLO LARRY J
Non-Executive Director
270,650 -34.1%
74.73
US$20,225,674 		270,650 -34.1% 74.73 US$20,225,674
Explore more

More insider trading research around CVS Health Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500